Sonoelastography for the Assessment of Muscle Changes in Amyotrophic Lateral Sclerosis: Results of a Pilot Study

The purpose of this study was to assess the sonoelastographic features of four different muscles in patients with amyotrophic lateral sclerosis compared with healthy controls and to evaluate the relationship of these features to muscle strength and other ultrasonographic variables. Fourteen patients...

Full description

Saved in:
Bibliographic Details
Published inUltrasound in medicine & biology Vol. 44; no. 12; pp. 2540 - 2547
Main Authors Martínez-Payá, Jacinto J., del Baño-Aledo, María Elena, Ríos-Díaz, José, Fornés-Ferrer, Victoria, Vázquez-Costa, Juan F.
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to assess the sonoelastographic features of four different muscles in patients with amyotrophic lateral sclerosis compared with healthy controls and to evaluate the relationship of these features to muscle strength and other ultrasonographic variables. Fourteen patients with amyotrophic lateral sclerosis and 20 controls were examined using strain sonoelastography scanning. The RGB channel fraction ratio was analyzed with ImageJ software (Version 1.48). Two main sonoelastographic patterns could be distinguished in the controls: a clear predominance of the blue channel (hard areas) and a more heterogeneous pattern with predominance of the green channel (intermediate stiffness). These patterns were also observed in patients, although a higher green channel score was observed in mildly impaired muscles, whereas a higher blue channel score was observed in the most severely impaired muscle. Sonoelastography may be a good complementary biomarker in the detection and monitoring of muscle changes in amyotrophic lateral sclerosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0301-5629
1879-291X
DOI:10.1016/j.ultrasmedbio.2018.08.009